CN104126802A - Composite solid beverage containing Lycium ruthenicum Murr and Phyllanthus emblica L. and preparation method thereof - Google Patents
Composite solid beverage containing Lycium ruthenicum Murr and Phyllanthus emblica L. and preparation method thereof Download PDFInfo
- Publication number
- CN104126802A CN104126802A CN201410405348.9A CN201410405348A CN104126802A CN 104126802 A CN104126802 A CN 104126802A CN 201410405348 A CN201410405348 A CN 201410405348A CN 104126802 A CN104126802 A CN 104126802A
- Authority
- CN
- China
- Prior art keywords
- emblic
- black fruit
- solid beverage
- fruit lyceum
- dry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 244000119298 Emblica officinalis Species 0.000 title claims abstract description 93
- 235000015489 Emblica officinalis Nutrition 0.000 title claims abstract description 93
- 235000013361 beverage Nutrition 0.000 title claims abstract description 37
- 239000007787 solid Substances 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 241000169546 Lycium ruthenicum Species 0.000 title abstract description 12
- 239000002131 composite material Substances 0.000 title abstract 4
- 239000000284 extract Substances 0.000 claims abstract description 51
- 239000000843 powder Substances 0.000 claims abstract description 29
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 239000007921 spray Substances 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000008187 granular material Substances 0.000 claims abstract description 9
- 235000013399 edible fruits Nutrition 0.000 claims description 95
- 150000001875 compounds Chemical class 0.000 claims description 18
- 238000001914 filtration Methods 0.000 claims description 8
- 238000005507 spraying Methods 0.000 claims description 8
- 238000005550 wet granulation Methods 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 238000005469 granulation Methods 0.000 claims description 4
- 230000003179 granulation Effects 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 229930091371 Fructose Natural products 0.000 claims description 3
- 239000005715 Fructose Substances 0.000 claims description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 239000011122 softwood Substances 0.000 claims description 3
- 235000020985 whole grains Nutrition 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 9
- 230000002929 anti-fatigue Effects 0.000 abstract description 6
- 238000000034 method Methods 0.000 abstract description 5
- 239000004480 active ingredient Substances 0.000 abstract description 4
- 238000000605 extraction Methods 0.000 abstract description 4
- 235000011869 dried fruits Nutrition 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 238000001035 drying Methods 0.000 abstract 1
- 238000003801 milling Methods 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- -1 phosphate amine Chemical class 0.000 description 9
- 239000000049 pigment Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 229920002527 Glycogen Polymers 0.000 description 7
- 235000010208 anthocyanin Nutrition 0.000 description 7
- 239000004410 anthocyanin Substances 0.000 description 7
- 229930002877 anthocyanin Natural products 0.000 description 7
- 150000004636 anthocyanins Chemical class 0.000 description 7
- 239000003963 antioxidant agent Substances 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 229940096919 glycogen Drugs 0.000 description 7
- 238000012856 packing Methods 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 230000001603 reducing effect Effects 0.000 description 6
- 230000009182 swimming Effects 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 230000002218 hypoglycaemic effect Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 235000015203 fruit juice Nutrition 0.000 description 4
- 230000002440 hepatic effect Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 2
- 108010082126 Alanine transaminase Proteins 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 241001106041 Lycium Species 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 150000004008 N-nitroso compounds Chemical class 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- 102100027265 Aldo-keto reductase family 1 member B1 Human genes 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 206010007026 Calculus urethral Diseases 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000221079 Euphorbia <genus> Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010063907 Glutathione Reductase Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 description 1
- 108010078851 HIV Reverse Transcriptase Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 241001130943 Phyllanthus <Aves> Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 229960002632 acarbose Drugs 0.000 description 1
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000029162 bladder disease Diseases 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 231100000005 chromosome aberration Toxicity 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000008965 mitochondrial swelling Effects 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 235000013930 proline Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011506 response to oxidative stress Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 201000009160 urethral calculus Diseases 0.000 description 1
- 208000026533 urinary bladder disease Diseases 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The invention discloses a composite solid beverage containing Lycium ruthenicum Murr and Phyllanthus emblica L., and a preparation method thereof. The composite solid beverage comprises the following raw materials in percentage by weight: Lycium ruthenicum Murr 40-80% and Phyllanthus emblica L. 20-60%. The preparation method comprises the following steps: pretreating the dried fruits of Lycium ruthenicum Murr and Phyllanthus emblica L., extracting the pretreated dried fruits of Lycium ruthenicum Murr and Phyllanthus emblica L. with water respectively, combining the extracts of the Lycium ruthenicum Murr and Phyllanthus emblica L., spray drying the mixture of the extracts to obtain a spray dry powder, uniformly mixing the spray dry powder with a powdered sugar, granulating the mixture powder by wet method, drying and milling the granules, so as to obtain the composite solid beverage containing Lycium ruthenicum Murr and Phyllanthus emblica L.. The Lycium ruthenicum Murr and Phyllanthus emblica L. are cooperatively used, so as to facilitate extraction of the active ingredients of the Lycium ruthenicum Murr, and strengthen the anti-oxidation and anti-fatigue action.
Description
Technical field
The present invention relates to a kind of health drink, be specifically related to a kind of black fruit lyceum emblic compound solid beverage and preparation method thereof.
Background technology
Black fruit lyceum be Solanaceae Lycium plant black fruit lyceum (
lycium Ruthenicummurr.) fruit, Tibetan medicine name " other agate ", because being atropurpureus after its fruit maturation, gain the name thus (seeing the Tibetan medicine and pharmacology classical works such as < < tetra-doctor's allusion quotation > >, < < Jingzhubencao > >).Black fruit lyceum taste is sweet, property flat, and the heat that clears away heart-fire, is used for the treatment of the illnesss such as cardiopyretic disease, heart disease, irregular menstruation, menelipsis.Except Tibetan medicine uses, black fruit lyceum all has use in Uygur nationality's medicine and pharmacology and Mongols's medicine and pharmacology, < < Uygur medicine will > > records, the conventional lycium ruthenicum fruit of the doctor of Uygur and root skin treatment urethral calculus, tinea scabies, gingiva bleeding gingival hemorrhage etc., among the people as strengthening by means of tonics, improving eyesight and depressor.Black fruit lyceum is distributed in the provinces and regions such as China Tibet, Qinghai, Xinjiang, North Shaanxi, West Inner Mongolia, Ningxia, Gansu.External in the Central Asia, all there is distribution north African and the various countries, southern Europe of Caucasia, Mongolia, Mediterranean.Modern scientific research shows, in nutritional labeling, black fruit lyceum has identical active ingredient with lycium barbarum.Show after measured, lycium ruthenicum fruit is containing a certain amount of essential fatty acid, alkaloid, phenols, protein, vitamin B1, B2 and Vc, and the amino acid that contains 18 kinds of needed by human, content with aspartic acid, glutamic acid, alanine and proline is higher, but majority is free state, account for 50% of total amino acid content, be conducive to human body and directly absorb.Trace element contained in while fruit is also very abundant, except macroelement Na, K, Mg, Ca, Fe, also contains a certain amount of micro-Mn, Sr, Se, Zn, Cr, Cu etc.The most meaningfully black fruit lyceum contains more reduced sugar and OPC (anthocyanin class pigment), and its sugared content is 6.9% after measured, higher than lycium barbarum, has far-reaching potentiality to be exploited.
Modern pharmacological research shows, black fruit lyceum and extract thereof have multiple pharmacological effect: 1. antioxidation: black fruit lyceum anthocyanin class pigment has certain oxidation resistance in chemical nature, has very strong DPPH free radical scavenging activity; Can significantly suppress mouse red blood cell haemolysis; Can strengthen mice serum resistant activity oxygen ability, suppress murine liver tissue lipid peroxidation product MDA and generate and Mouse Liver mitochondrial swelling degree.2. antifatigue effect: black fruit lyceum anthocyanin class pigment can strengthen the hypoxia-bearing capability of mouse, and is dose-dependence; Add low dosage Assessment of Pigment of Lycium ruthenicum Murr and can extend the mice burden swimming duration.3. hypoglycemic activity: black fruit lyceum polysaccharide can significantly reduce the blood-sugar content of diabetic mice, strengthens diabetic mice serum and liver SOD active, reduces its serum and liver MDA content, and can promote that glucose changes hepatic glycogen into.4. effect for reducing blood fat: it is active that black fruit lyceum anthocyanin class pigment can also strengthen in hyperlipidemia model Mice Body antioxidase SOD, GSH-PX, reducing MDA produces, rising serum TC, TG content, reduce LDL-c content, illustrate that this pigment has certain reducing blood lipid and suppresses Antioxidation.5. delaying senility function: it is active that black fruit lyceum anthocyanin class pigment can significantly improve in aging model serum and each organ-tissue SOD, significantly reduces wherein MDA content, illustrates that black fruit lyceum anthocyanin class pigment has delaying senility function.6. strengthen immunization: black fruit lyceum anthocyanin class pigment has enhancing immunity function to the hypoimmunity mouse being caused by cycli phosphate amine.
Emblic is euphorbia plant emblic
phyllanthus emblical. fruit, bright < < Compendium of Materia Medica > > records: " clothes are made light of one's life by commiting suicide for a long time, promote longevity for emblic fruit, main help gas ".As one of three large fruits of the high nutrition of China, emblic fruit cold nature, acid, sweet, cool, puckery.Attach to the lung and stomach meridians, the effect that it has the cough-relieving of promoting the production of body fluid, clearing heat and cooling blood, food digesting stomach fortifying, can be used for the symptoms such as blood-head blood addiction, indigestion, liver and bladder disease, cough, laryngalgia, dry, stomachache.Prevent and treat fatty liver, diabetes, high fat of blood, hypertension, obesity, cancer, can strengthen the immunity of human body, fundamentally improve the capacity of decomposition of human body lipid and reach the object of balance metabolism.Therefore, it is the natural treasure of the best that people resist aging, lowering blood-fat and reducing weight, is described as " life is fruit ".
In emblic fruit, contain multivitamin, comprising vitamin B1, vitamin B2, vitamin C and carrotene etc., wherein especially high and famous with Vit C contents.The Vit C contents that has bibliographical information emblic is 200-1560 mg/100g, and China's emblic vitamin C is general large more than 300mg/100g, and average content is 100 times of oranges and tangerines, is 160 times of apple.In addition, in emblic fruit, also contain the materials such as aldehydes matter, organic acid, carbohydrate, amino acid and trace elements zn, Mn, Fe, Ca and Se etc.
At present, the medical value of emblic has been carried out to more deep research both at home and abroad, mainly comprised the following aspects.
1. remove free radical and antioxidation: research finds that emblic crude extract has antioxidation, can improve the elderly's erythrocyte sod active, reduces lipid peroxide (LPO) content in blood plasma.Zoopery confirms, emblic affects the radical reaction in rat body, can significantly improve the peroxide scavenger enzyme (SOD of high cholesterol mouse, catalase, glutathione peroxidase, glutathione reductase) vigor and relative Zn, Cu level, the content of reduction lipid peroxide (LPO).Researcher finds; emblic has the free radical of removing and antioxidation; be to have an antioxidant system that comprises that vitamin C, polysaccharide and Polyphenols etc. become to be grouped into because it is inner, strengthened endogenic antioxidant as the activity of SOD etc., Cell protection is resisted response to oxidative stress.
2. reducing blood lipid and antiatherosclerosis: the emblic fruit juice effect that the impact of bait Hyperlipidemia Rabbits blood lipid level and antiatherosclerosis are formed that had scholar's research, find that emblic fruit juice can significantly reduce Blood Cholesterol and blood lipid level, the effect that has good antiatherosclerosis to form, this effect may be relevant with the non-oxidizability of VC.
3. anti-liver injury effect: research shows that the aqueous extract of emblic suppresses the generation of liver cell lipid peroxide in vitro, and the extract of emblic can also be alleviated D-galactosamine and CCl
4the chmice acute and the Chronic Liver that cause are poisoning, reduce the level of liver lipid peroxide (LPO), glutamic-pyruvic transaminase (GPT) and alkaline phosphatase lipase (ALP), prevent liver fibrosis.
4. resisting pathogenic microbes and antiinflammatory action: there are some researches show that emblic aqueous extract has stronger inhibitory action to causing the fungi of dermatitis, also can be used for treating intestines problem, especially for multidrug resistant salmonella, have good inhibitory action.
5. anti-mutagenesis, teratogenesis and antitumor action: it is reported that clastogenisity and cell mutation that emblic extract causes lead, aluminium, nickel have significant inhibitory action, and the cytotoxic that arsenic is caused and chromosome aberration have protective effect.Emblic extract can the mutagenesis of Antagonistic Environment chemokines to mammalian cell, and this effect is better than the vitamin C of Isodose.In addition, emblic fruit juice can be blocked the synthetic of the interior carcinogenic substance N-nitroso compound (NNC) of animal body effectively, and its blocking-up rate is obviously superior to vitamin C.In addition, the norsesquiterpenoid lactone class material in emblic extract and polyphenols can inhibition cancer cell MK-1, HeLa and the propagation of B16F10.
6. hypoglycemic and improve diabetic complication: emblic water extraction liquid and methyl alcohol extract can significantly suppress the effect of alpha-glucosidase, reduce the blood sugar level of rat, its hypoglycemic activity is better than hypoglycemic medicine acarbose.In addition, emblic alcohol extract can suppress aldose reductase in vitro and in vivo, thus the cataract that prevention diabetes cause.
7. improve immunologic function: the immunologic function that emblic fruit can improve human body has imperial anti-, treatment and resistant function to various diseases.Emblic has the obvious inhibitory action to HIV reverse transcriptase.Adopt cell virus to suppress method and promote the result of study of HLI's nucleus formation to show to emblic fruit juice, the liquid of the multiple different content of emblic all has the effect that promotes to induce HLI.Emblic can also improve the bioavailability of the iron ion in cereal and beans, thereby can enhanced machine body immunity function, improves human body resistance against diseases.
The effects such as that black fruit lyceum and emblic all have is anti-oxidant, antifatigue, hypoglycemic, reducing blood lipid, enhancing immunity.Experimental study shows, black fruit lyceum and emblic are used in conjunction with, and have good synergy, can strengthen the effect of the aspect such as anti-oxidant, antifatigue, enhancing immunity of the two.In addition, in black fruit lyceum, contain a large amount of OPCs, due under acid condition, this constituents is more stable, therefore, how the extraction of black fruit lyceum, carry out in acidic ethanol or the aqueous solution, general for multiselect hydrochloric acid, citric acid, ascorbic acid etc. as external acid source, regulate the pH value of solvent, external acid source add the quality that may finally affect product, and, also increase to a certain extent cost, for production environment, also had certain threat.And the present invention is used in conjunction with emblic and black fruit lyceum; in emblic, contain a large amount of vitamin Cs; the two extracts simultaneously; can play the effect of effective protection OPC; be beneficial to and extend extraction time; guarantee the extraction effect of other active ingredients such as reduced sugar in black fruit lyceum, reach the result of use of final products.At present, black fruit lyceum and emblic are used in conjunction with, for Food and hygienical food aspect, there are no corresponding product, meanwhile, also there are no report.
Summary of the invention
The object of the invention is to: provide that a kind of to take black fruit lyceum, emblic be raw material, be beneficial to compound solid beverage formula and the preparation technology of anti-oxidant, antifatigue, enhancing immunity.
The technical solution adopted in the present invention is: a kind of black fruit lyceum emblic compound solid beverage, and take black fruit lyceum, emblic is primary raw material, each raw material content is by mass percentage: black fruit lyceum 40% ~ 80%, emblic 20% ~ 60%.
The preparation method of described black fruit lyceum emblic compound solid beverage comprises the following steps:
(1) pretreatment of raw material: black fruit lyceum and emblic dry fruit are cleaned up, dry, pulverize, cross 20 mesh sieves;
(2) extract: by black fruit lyceum and emblic leafflower powder, add the water of 8 ~ 15 times according to mass ratio, extract 60 ~ 120min at 40 ~ 60 ℃, extracts three times, filtration, obtains extract;
(3) spraying is dry: the extract in (2) is merged, and the spray-dried dry powder that obtains, standby;
(4) granulate: the spray powder that (3) are obtained mixes with Icing Sugar, wet granulation, dries, and after whole grain, obtains black fruit lyceum emblic compound solid beverage.
In step (2), black fruit lyceum and emblic extract by described method, and the recovery rate of active ingredient (OPC, polysaccharide etc.) is 85%-95%.
In step (4), described Icing Sugar be in sucrose, glucose, lactose, fructose etc. wherein one or both and more than, the addition of Icing Sugar, according to gained spray powder mass ratio (1 ~ 3): 1 adds, and add appropriate 70% edible ethanol, principle according to " that holds is agglomerating, and light pressure fallen apart " is prepared softwood; Described granulation, adopts oscillating granulator, by softwood granulation on 18 ~ 20 eye mesh screens; Described oven dry, can adopt heated-air circulation oven constant pressure and dry 3 ~ 5 hours at 60 ~ 80 ℃, crosses the whole grain of 14 mesh sieves; Gained pellet moisture content ﹤ 6%.Gained particle is distributed into 10g/ bag or 15g/ bag through packing machine.
The specific embodiment
Below optimum implementation of the present invention is described in further detail.
Embodiment 1
Black fruit lyceum 500g, emblic 500g
(1) pretreatment of raw material: black fruit lyceum and emblic dry fruit are cleaned up, dry, pulverize, cross 20 mesh sieves;
(2) extract: by (1) Raw powder, add the water of 8 times according to mass ratio, extract 90min at 50 ℃, extract three times, filtration, obtains extract;
(3) spraying is dry: the extract in (2) is merged, and the spray-dried dry powder that obtains, standby;
(4) granulate: the spray powder that (3) are obtained mixes with the sucrose Icing Sugar of 1 times of quality, wet granulation, adopts heated-air circulation oven constant pressure and dry 5 hours at 60 ℃, and whole of mistake 14 mesh sieves, obtain black fruit lyceum emblic compound solid beverage.Gained particle is distributed into 10g/ bag through packing machine.
Embodiment 2
Black fruit lyceum 650g, emblic 350g
(1) pretreatment of raw material: black fruit lyceum and emblic dry fruit are cleaned up, dry, pulverize, cross 20 mesh sieves;
(2) extract: by (1) Raw powder, add the water of 12 times according to mass ratio, extract 120min at 40 ℃, extract three times, filtration, obtains extract;
(3) spraying is dry: the extract in (2) is merged, and the spray-dried dry powder that obtains, standby;
(4) granulate: the spray powder that (3) are obtained mixes with the glucose Icing Sugar of 2 times of quality, wet granulation, employing heated-air circulation oven constant pressure and dry 4 hours at 70 ℃, whole of mistake 14 mesh sieves, obtain black fruit lyceum emblic compound solid beverage.Gained particle is distributed into 15g/ bag through packing machine.
Embodiment 3
Black fruit lyceum 800g, emblic 200g
(1) pretreatment of raw material: black fruit lyceum and emblic dry fruit are cleaned up, dry, pulverize, cross 20 mesh sieves;
(2) extract: by (1) Raw powder, add the water of 10 times according to mass ratio, extract 100min at 60 ℃, extract three times, filtration, obtains extract;
(3) spraying is dry: the extract in (2) is merged, and the spray-dried dry powder that obtains, standby;
(4) granulate: the spray powder that (3) are obtained mixes with the lactose Icing Sugar of 1 times of quality, wet granulation, employing heated-air circulation oven constant pressure and dry 5 hours at 60 ℃, whole of mistake 14 mesh sieves, obtain black fruit lyceum emblic compound solid beverage.Gained particle is distributed into 10g/ bag through packing machine.
Embodiment 4
Black fruit lyceum 400g, emblic 600g
(1) pretreatment of raw material: black fruit lyceum and emblic dry fruit are cleaned up, dry, pulverize, cross 20 mesh sieves;
(2) extract: by (1) Raw powder, add the water of 15 times according to mass ratio, extract 100min at 55 ℃, extract three times, filtration, obtains extract;
(3) spraying is dry: the extract in (2) is merged, and the spray-dried dry powder that obtains, standby;
(4) granulate: the spray powder that (3) are obtained mixes with the fructose Icing Sugar of 2 times of quality, wet granulation, adopts heated-air circulation oven constant pressure and dry 3 hours at 80 ℃, and whole of mistake 14 mesh sieves, obtain black fruit lyceum emblic compound solid beverage.Gained particle is distributed into 15g/ bag through packing machine.
Embodiment 5
Black fruit lyceum 600g, emblic 400g
(1) pretreatment of raw material: black fruit lyceum and emblic dry fruit are cleaned up, dry, pulverize, cross 20 mesh sieves;
(2) extract: by (1) Raw powder, add the water of 11 times according to mass ratio, extract 120min at 60 ℃, extract three times, filtration, obtains extract;
(3) spraying is dry: the extract in (2) is merged, and the spray-dried dry powder that obtains, standby;
(4) granulate: the spray powder that (3) are obtained mixes with the sucrose Icing Sugar of 3 times of quality, wet granulation, adopts heated-air circulation oven constant pressure and dry 4 hours at 60 ℃, and whole of mistake 14 mesh sieves, obtain black fruit lyceum emblic compound solid beverage.Gained particle is distributed into 10g/ bag through packing machine.
Embodiment 6
Black fruit lyceum 750g, emblic 250g
(1) pretreatment of raw material: black fruit lyceum and emblic dry fruit are cleaned up, dry, pulverize, cross 20 mesh sieves;
(2) extract: by (1) Raw powder, add the water of 10 times according to mass ratio, extract 120min at 70 ℃, extract three times, filtration, obtains extract;
(3) spraying is dry: the extract in (2) is merged, and the spray-dried dry powder that obtains, standby;
(4) granulate: the spray powder that (3) are obtained mixes with the grape beach Icing Sugar of 3 times of quality, wet granulation, adopts heated-air circulation oven constant pressure and dry 4 hours at 70 ℃, and whole of mistake 14 mesh sieves, obtain black fruit lyceum emblic compound solid beverage.Gained particle is distributed into 10g/ bag through packing machine.
Embodiment 7
Functional experiment of the present invention
Adopt the solid beverage of above-described embodiment 1 formula preparation, carry out antifatigue experiment in antioxidation in vitro experiment and body.
1.1 solid beverage antioxidation in vitro experimental results of the present invention
1.1.1DPPH method
Table 1 solid beverage of the present invention is on the impact of DPPH free radical scavenging activity (%)
The result of table 1 shows, under same isoconcentration, solid beverage of the present invention higher than black fruit lyceum and emblic, illustrates that the two is used in conjunction with to the clearance rate of DPPH free radical, can improve to a certain extent the clearance rate to DPPH free radical.
1.1.2 hydroxy radical method
Table 2 solid beverage of the present invention is on the impact of Scavenging action to hydroxyl free radical (%)
As shown in Table 2, under same isoconcentration, solid beverage of the present invention apparently higher than independent use black fruit lyceum and emblic, illustrates that the two is used in conjunction with to the clearance rate of hydroxy radical, can obviously improve the clearance rate to hydroxy radical.
The presentation of results of above-mentioned anti-oxidant experiment, solid beverage of the present invention is used in conjunction with black fruit lyceum and emblic, has obvious antioxidation, and oxidation resistance is better than both and applies separately.
1.2 impacts of solid beverage of the present invention on Tolerance of Swimming
Table 3 solid beverage of the present invention on the impact of Tolerance of Swimming (
± SD, n=10)
| Group | Dosage (mgkg -1) | Swimming time (min) | Hepatic glycogen content (g/100g) | Muscle glycogen content (g/100g) |
| Normal group | - - | 190.13±52.65 | 4.44±1.03 | 0.44±0.12 |
| Black fruit lyceum emblic solid beverage | 50 | 323.23±57.62** ΔΔ | 13.65±2.08** ΔΔ | 1.31±0.45** ΔΔ |
| Black fruit lyceum | 50 | 291.58±70.20** Δ | 10.02±1.65** Δ | 1.12±0.53** Δ |
| Emblic | 50 | 235.55±63.67* | 7.13±1.91* | 0.75±0.18* |
Note: with the comparison of blank group: * P<0.05, * * P<0.01; With the comparison of emblic subgroup: Δ P<0.05, Δ Δ P<0.01.
Result is as shown in table 3, with Normal group comparison, black fruit lyceum emblic solid beverage group, black fruit lyceum group, emblic subgroup mouse swimming time obviously extend (P<0.05-0.01), and hepatic glycogen and muscle glycogen content obviously increase (P<0.05-0.01); Black fruit lyceum emblic solid beverage group and black fruit lyceum group and the comparison of emblic subgroup, swimming time, hepatic glycogen and muscle glycogen content all have significantly increases (P<0.05-0.01); And black fruit lyceum emblic solid beverage group is compared with black fruit lyceum group, although there was no significant difference, experimental result demonstration, the indices of solid beverage group is all higher than black fruit lyceum group.The explanation of this experimental result, black fruit lyceum and emblic are used in conjunction with, and delay fatigue effect is better than the independent application of black fruit lyceum and emblic, and the two has obvious chemiluminescence.
Comprehensive above-mentioned functions experimental result, solid beverage of the present invention has anti-oxidant and alleviates fatigue effect, and black fruit lyceum and emblic are used in conjunction with, and have obvious synergy.
Claims (5)
1. a black fruit lyceum emblic compound solid beverage, is characterized in that its raw material forms and content is by mass percentage: black fruit lyceum 40% ~ 80%, emblic 20% ~ 60%.
2. the preparation method of black fruit lyceum emblic compound solid beverage as claimed in claim 1, is characterized in that comprising the following steps:
(1) pretreatment of raw material: black fruit lyceum and emblic dry fruit are cleaned up, dry, pulverize, cross 20 mesh sieves;
(2) extract: by black fruit lyceum and emblic leafflower powder, add the water of 8 ~ 15 times according to mass ratio, extract 60 ~ 120min at 40 ~ 60 ℃, extracts three times, filtration, obtains extract;
(3) spraying is dry: extract is merged, and the spray-dried dry powder that obtains, standby;
(4) granulate: spray powder is mixed with Icing Sugar, and wet granulation, dries, and after whole grain, obtains black fruit lyceum emblic compound solid beverage.
3. the preparation method of black fruit lyceum emblic compound solid beverage as claimed in claim 2, it is characterized in that in step (4), described Icing Sugar be in sucrose, glucose, lactose, fructose etc. wherein one or both and more than, the addition of Icing Sugar, according to adding with gained spray powder mass ratio 1 ~ 3:1.
4. the preparation method of black fruit lyceum emblic compound solid beverage as claimed in claim 2, is characterized in that in step (4), and described granulation is for adopting oscillating granulator, by softwood granulation on 18 ~ 20 eye mesh screens.
5. the preparation method of black fruit lyceum emblic compound solid beverage as claimed in claim 2, is characterized in that in step (4), and described oven dry is for adopting heated-air circulation oven constant pressure and dry 3 ~ 5 hours at 60 ~ 80 ℃.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410405348.9A CN104126802B (en) | 2014-08-18 | 2014-08-18 | A kind of black fruit lyceum emblic compound solid beverage and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410405348.9A CN104126802B (en) | 2014-08-18 | 2014-08-18 | A kind of black fruit lyceum emblic compound solid beverage and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104126802A true CN104126802A (en) | 2014-11-05 |
| CN104126802B CN104126802B (en) | 2016-04-06 |
Family
ID=51799852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410405348.9A Active CN104126802B (en) | 2014-08-18 | 2014-08-18 | A kind of black fruit lyceum emblic compound solid beverage and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104126802B (en) |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104585834A (en) * | 2015-01-30 | 2015-05-06 | 广州泽力医药科技有限公司 | Natural herbaceous plant solid beverage with immunological enhancement effect and preparation method of natural herbaceous plant solid beverage |
| CN104605436A (en) * | 2015-03-03 | 2015-05-13 | 浙江小二黑食品有限公司 | Preparation method of lycium ruthenicum-apricot kernel-pumpkin compound beverage |
| CN104621652A (en) * | 2015-01-28 | 2015-05-20 | 青海省轻工业研究所有限责任公司 | Lycium ruthenicum juice beverage and preparation method thereof |
| CN104839835A (en) * | 2015-05-27 | 2015-08-19 | 中国科学院西北高原生物研究所 | Preparation method of purple potato, hawthorn and lemon compound beverage |
| CN104921217A (en) * | 2015-05-27 | 2015-09-23 | 中国科学院西北高原生物研究所 | Lycium ruthenicum fruit, haw and lemon compound beverage preparation method |
| CN105029624A (en) * | 2015-09-06 | 2015-11-11 | 青海之也科技咨询服务有限公司 | Lycium ruthenicum Murr. beverage and preparing method thereof |
| CN105053417A (en) * | 2015-09-06 | 2015-11-18 | 青海之也科技咨询服务有限公司 | Lycium ruthenicum Murr tea drink and preparation method thereof |
| CN105124070A (en) * | 2015-09-06 | 2015-12-09 | 青海之也科技咨询服务有限公司 | Chinese wolfberry fruit flavored health-care tea and preparation method thereof |
| CN105309679A (en) * | 2015-11-09 | 2016-02-10 | 吴蓓蓓 | Preparation method for health care phyllanthus emblica tea powder |
| CN105613834A (en) * | 2016-01-15 | 2016-06-01 | 云南省农业科学院热区生态农业研究所 | Formula of solid phyllanthus emblica tea and preparation method thereof |
| CN105941733A (en) * | 2016-04-11 | 2016-09-21 | 甘肃大禹黑枸杞农业科技有限公司 | Lycium ruthenicm murr solid fruit tea |
| CN107334029A (en) * | 2017-07-28 | 2017-11-10 | 江苏南大耐雀生物技术有限公司 | A kind of face nourishing antidebilitation solid beverage formula and preparation method thereof |
| CN107467463A (en) * | 2017-08-29 | 2017-12-15 | 江苏耐雀生物工程技术有限公司 | A kind of preparation method and application for antifatigue solid beverage of refreshing oneself |
| CN107684000A (en) * | 2017-09-01 | 2018-02-13 | 青海汇彩生物科技开发有限公司 | A kind of health care, the solid beverage and preparation method thereof of beauty |
| CN107873846A (en) * | 2017-11-15 | 2018-04-06 | 南阳理工学院 | A kind of Poria cocos emblic modulation breast |
| CN108244441A (en) * | 2017-12-29 | 2018-07-06 | 吉林新开河食品有限公司 | A kind of ginseng black fruit fructus lycii solid beverage and preparation method thereof |
| CN108450719A (en) * | 2018-04-18 | 2018-08-28 | 凉山州晟森生物科技有限公司 | A kind of preparation process of potato emblic composite beverage |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1171290A (en) * | 1997-08-27 | 1999-03-16 | Takara Shuzo Co Ltd | Hyaluronidase inhibitor and food and beverage containing the same |
| CN101642246A (en) * | 2009-08-21 | 2010-02-10 | 陈子刚 | Method for preparing emblic leafflower powder |
| CN102793030A (en) * | 2012-07-29 | 2012-11-28 | 天马（安徽）中药饮片科技有限公司 | Wuziyansheng plant teabag and production technology thereof |
| CN103211061A (en) * | 2013-04-26 | 2013-07-24 | 青海紫阳生物科技有限公司 | Wild black medlar teabag and making method thereof |
-
2014
- 2014-08-18 CN CN201410405348.9A patent/CN104126802B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1171290A (en) * | 1997-08-27 | 1999-03-16 | Takara Shuzo Co Ltd | Hyaluronidase inhibitor and food and beverage containing the same |
| CN101642246A (en) * | 2009-08-21 | 2010-02-10 | 陈子刚 | Method for preparing emblic leafflower powder |
| CN102793030A (en) * | 2012-07-29 | 2012-11-28 | 天马（安徽）中药饮片科技有限公司 | Wuziyansheng plant teabag and production technology thereof |
| CN103211061A (en) * | 2013-04-26 | 2013-07-24 | 青海紫阳生物科技有限公司 | Wild black medlar teabag and making method thereof |
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104621652A (en) * | 2015-01-28 | 2015-05-20 | 青海省轻工业研究所有限责任公司 | Lycium ruthenicum juice beverage and preparation method thereof |
| CN104585834A (en) * | 2015-01-30 | 2015-05-06 | 广州泽力医药科技有限公司 | Natural herbaceous plant solid beverage with immunological enhancement effect and preparation method of natural herbaceous plant solid beverage |
| CN104605436A (en) * | 2015-03-03 | 2015-05-13 | 浙江小二黑食品有限公司 | Preparation method of lycium ruthenicum-apricot kernel-pumpkin compound beverage |
| CN104839835A (en) * | 2015-05-27 | 2015-08-19 | 中国科学院西北高原生物研究所 | Preparation method of purple potato, hawthorn and lemon compound beverage |
| CN104921217A (en) * | 2015-05-27 | 2015-09-23 | 中国科学院西北高原生物研究所 | Lycium ruthenicum fruit, haw and lemon compound beverage preparation method |
| CN104921217B (en) * | 2015-05-27 | 2017-06-06 | 中国科学院西北高原生物研究所 | A kind of black fruit fructus lycii, hawthorn, the preparation method of lemon composite beverage |
| CN105029624A (en) * | 2015-09-06 | 2015-11-11 | 青海之也科技咨询服务有限公司 | Lycium ruthenicum Murr. beverage and preparing method thereof |
| CN105053417A (en) * | 2015-09-06 | 2015-11-18 | 青海之也科技咨询服务有限公司 | Lycium ruthenicum Murr tea drink and preparation method thereof |
| CN105124070A (en) * | 2015-09-06 | 2015-12-09 | 青海之也科技咨询服务有限公司 | Chinese wolfberry fruit flavored health-care tea and preparation method thereof |
| CN105309679A (en) * | 2015-11-09 | 2016-02-10 | 吴蓓蓓 | Preparation method for health care phyllanthus emblica tea powder |
| CN105613834B (en) * | 2016-01-15 | 2018-11-27 | 云南省农业科学院热区生态农业研究所 | A kind of formula and preparation method thereof of emblic solid tea |
| CN105613834A (en) * | 2016-01-15 | 2016-06-01 | 云南省农业科学院热区生态农业研究所 | Formula of solid phyllanthus emblica tea and preparation method thereof |
| CN105941733A (en) * | 2016-04-11 | 2016-09-21 | 甘肃大禹黑枸杞农业科技有限公司 | Lycium ruthenicm murr solid fruit tea |
| CN107334029A (en) * | 2017-07-28 | 2017-11-10 | 江苏南大耐雀生物技术有限公司 | A kind of face nourishing antidebilitation solid beverage formula and preparation method thereof |
| CN107467463A (en) * | 2017-08-29 | 2017-12-15 | 江苏耐雀生物工程技术有限公司 | A kind of preparation method and application for antifatigue solid beverage of refreshing oneself |
| CN107684000A (en) * | 2017-09-01 | 2018-02-13 | 青海汇彩生物科技开发有限公司 | A kind of health care, the solid beverage and preparation method thereof of beauty |
| CN107873846A (en) * | 2017-11-15 | 2018-04-06 | 南阳理工学院 | A kind of Poria cocos emblic modulation breast |
| CN108244441A (en) * | 2017-12-29 | 2018-07-06 | 吉林新开河食品有限公司 | A kind of ginseng black fruit fructus lycii solid beverage and preparation method thereof |
| CN108450719A (en) * | 2018-04-18 | 2018-08-28 | 凉山州晟森生物科技有限公司 | A kind of preparation process of potato emblic composite beverage |
| CN108450719B (en) * | 2018-04-18 | 2021-05-28 | 凉山州晟森生物科技有限公司 | Preparation process of potato and emblic leafflower fruit compound beverage |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104126802B (en) | 2016-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104126802B (en) | A kind of black fruit lyceum emblic compound solid beverage and preparation method thereof | |
| Agunbiade et al. | Hypoglycaemic activity of Commelina africana and Ageratum conyzoides in relation to their mineral composition | |
| CN102106580B (en) | Sobering-up and liver-protecting health beverage | |
| CN105105256A (en) | Hydrogen-enriched health beverage and preparation method thereof | |
| CN105876548A (en) | Fruit and vegetable drink with maca and radix ginseng, method for preparing fruit and vegetable drink and application thereof | |
| CN103168883A (en) | Pathogenic microorganism preventing antiviral tea beverage granules capable of boosting immunity and preparation method thereof | |
| CN103141662B (en) | Method for extracting amino acid from fat-extracted walnut protein and composition containing the amino acid | |
| CN103006922A (en) | Composition having function of relieving alcoholism to protect liver | |
| CN112586698A (en) | Liver-protecting composition and preparation method thereof | |
| CN110771767A (en) | Chinese wolfberry leaf solid beverage for relieving visual fatigue and preparation method thereof | |
| CN101530227A (en) | Houttuynia cordata thunb rosa roxburghii tratt. beverage | |
| CN104172048A (en) | Nutritious bamboo juice seasoning and preparation method thereof | |
| CN111296598B (en) | Composite black jerusalem artichoke sports tea beverage and preparation method thereof | |
| KR100337472B1 (en) | Health food beverage composition containing prickly pear extract | |
| KR101894491B1 (en) | A composition for improving memory or cognitive function comprising a aurantii fructus immaturus supercritical extract as an active ingredient | |
| CN103734420B (en) | Rosaroxbunghii and dianthus chinensis tea and making method for same | |
| KR101470337B1 (en) | Concentrated functionality drink comprising unripened black raspberry and manufacturing method thereof | |
| CN102511870A (en) | Thickened red jujube pulp beneficial to losing weight | |
| CN112691150A (en) | Composition and preparation method and application thereof | |
| CN111011667A (en) | Preparation method of walnut kernel and skin health-care beverage with functions of reducing phlegm and relieving asthma | |
| CN104323119B (en) | Composite nutrient enrichment rice with functions of resisting fatigue and improving memory, and preparation method of composite nutrient enrichment rice | |
| CN109170592A (en) | A kind of radix tetrastigme polysaccharide liver protection dilated food and preparation method thereof | |
| KR20140064067A (en) | Compositions for preventing and treating diabetes or diabetic complications comprising extracts of zanthoxylum piperitum and piper nigrum | |
| CN108477614A (en) | Blackberry, blueberry composition and preparation method thereof for improving sleep quality | |
| CN102640893A (en) | Black malt and whole herb composite nutrient and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |